Aug 06, 2024 7:00 am EDT MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
Jul 17, 2024 7:00 am EDT MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
Jun 21, 2024 7:00 am EDT MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Jun 20, 2024 7:00 am EDT MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)